Phytocannabinoids in neurological diseases: could they restore a physiological GABAergic transmission?

P Cifelli, G Ruffolo, E De Felice, V Alfano… - International journal of …, 2020 - mdpi.com
γ-Aminobutyric acid type A receptors (GABAARs) are the main inhibitory mediators in the
central nervous system (CNS). GABAARs are pentameric ligand gated ion channels, and the …

The adverse-effect profile of lacosamide

J Li, M Sun, X Wang - Expert Opinion on Drug Safety, 2020 - Taylor & Francis
Introduction: Lacosamide has been used in epilepsy patients in the United States, Europe
and Asia since it was approved by the FDA in 2008. Many patients have benefited from this …

GABAA receptor function is enhanced by Interleukin-10 in human epileptogenic gangliogliomas and its effect is counteracted by Interleukin-1β

G Ruffolo, V Alfano, A Romagnolo, T Zimmer, JD Mills… - Scientific reports, 2022 - nature.com
Gangliogliomas (GGs) are low-grade brain tumours that cause intractable focal epilepsy in
children and adults. In GG, as in epileptogenic focal malformations (ie, tuberous sclerosis …

The “www” of Xenopus laevis Oocytes: The Why, When, What of Xenopus laevis Oocytes in Membrane Transporters Research

M Bhatt, A Di Iacovo, T Romanazzi, C Roseti… - Membranes, 2022 - mdpi.com
After 50 years, the heterologous expression of proteins in Xenopus laevis oocytes is still
essential in many research fields. New approaches and revised protocols, but also classical …

Human iPSC modeling of genetic febrile seizure reveals aberrant molecular and physiological features underlying an impaired neuronal activity

S Scalise, C Zannino, V Lucchino, M Lo Conte… - Biomedicines, 2022 - mdpi.com
Mutations in SCN1A gene, encoding the voltage-gated sodium channel (VGSC) NaV1. 1,
are widely recognized as a leading cause of genetic febrile seizures (FS), due to the …

Pharmacology of lacosamide: from its molecular mechanisms and pharmacokinetics to future therapeutic applications

A Carona, J Bicker, R Silva, C Fonseca, A Falcão… - Life Sciences, 2021 - Elsevier
Epilepsy is one of the most common brain disorders, affecting more than 50 million people
worldwide. Although its treatment is currently symptomatic, the last generation of anti-seizure …

Using Xenopus oocytes in neurological disease drug discovery

SL Zeng, LC Sudlow, MY Berezin - Expert opinion on drug …, 2020 - Taylor & Francis
Introduction: Neurological diseases present a difficult challenge in drug discovery. Many of
the current treatments have limited efficiency or result in a variety of debilitating side effects …

[PDF][PDF] Documento de consenso para el tratamiento del paciente con crisis epiléptica urgente.

I García Morales, C Fernández Alonso… - …, 2020 - researchgate.net
El presente documento de consenso se ha desarrollado con el objetivo de optimizar el
tratamiento de pacientes con crisis epilépticas (CE) en los ámbitos de urgencias …

[PDF][PDF] Time course evaluation of lacosamide alone and in polypharmacy on behavioral manifestations and oxidative stress in lithium-pilocarpine-induced model

W Shakeel, S Javaid, SMM Anjum, MF Rasool… - J. Physiol …, 2020 - jpp.krakow.pl
The lithium-pilocarpine model in rats is commonly used to study the characteristic events of
acute status epilepticus (SE), epileptogenesis and temporal lobe epilepsy (TLE). Here we …

[HTML][HTML] Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion

R Sankar, M Chez, JE Pina-Garza… - … : European Journal of …, 2023 - Elsevier
Lennox-Gastaut syndrome (LGS) is a severe, chronic, complex form of early childhood-onset
epilepsy characterized by multiple seizure types, generalized slow (≤ 2.5 Hz) spike-and …